Domov › Rakovina (všetky typy) › Ohio › Cincinnati
Klinické štúdie Rakovina (všetky typy) v meste Cincinnati, OH
27 štúdií pre Rakovina (všetky typy) hľadá účastníkov v zariadeniach v meste Cincinnati a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Prebieha náborFáza 2
- University of Cincinnati Medical Center. /ID# 278925, Cincinnati
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Prebieha náborFáza 3
- Oncology Hematology Care Clinical Trials, LLC, Fairfield · 15 míľ odtiaľ
Registry Study for Radiation Therapy Outcomes
Prebieha náborObservačná štúdia
- University of Cincinnati Medical Center, Cincinnati
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Prebieha náborFáza 3
- Saint Elizabeth Medical Center Edgewood, Edgewood · 8 míľ odtiaľ
A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer
Prebieha nábor
- Cincinnati Children's Hospital Medical Center, Cincinnati
Pan Tumor Rollover Study
Prebieha náborFáza 2
- Oncology Hematology Care, Cincinnati
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Prebieha náborFáza 3
- Oncology Hematology Care - Fairfield /ID# 280641, Fairfield · 15 míľ odtiaľ
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Prebieha náborFáza 2
- University of Cincinnati Medical Center, Cincinnati
- West Chester Hospital, West Chester · 15 míľ odtiaľ
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Prebieha náborFáza 2/3
- Oncology Hematology Care, Inc., Cincinnati
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
Prebieha náborFáza 3
- Research Site, Edgewood · 8 míľ odtiaľ
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Prebieha náborFáza 3
- USO - Oncology Hematology Care, Cincinnati
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Prebieha náborObservačná štúdia
- University of Cincinnati, Cincinnati
Project: Every Child for Younger Patients With Cancer
Prebieha náborObservačná štúdia
- Cincinnati Children's Hospital Medical Center, Cincinnati
International Rare Brain Tumor Registry
Prebieha náborObservačná štúdia
- Cincinnati Children's Hospital Medical Center, Cincinnati
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Prebieha náborFáza 3
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
- TriHealth Cancer Institute-Westside, Cincinnati
- a 1 ďalších
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Prebieha náborFáza 3
- University of Cincinnati Physicians Group, LLC, Cincinnati
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Prebieha náborFáza 1/2
- Oncology Hematology Care - Blue Ash /ID# 272918, Cincinnati
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Prebieha náborFáza 1
- University Of Cincinnati Medical Center /ID# 251746, Cincinnati
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
Prebieha náborObservačná štúdia
- TriHealth Cancer Institute, Cincinnati
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
Prebieha náborFáza 1/2
- University of Cincinnati, Cincinnati
Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors
Prebieha náborFáza 2
- University of Cincinnati Medical Center, Cincinnati
GEMINI-NSCLC: NSCLC Biomarker Study
Prebieha náborObservačná štúdia
- TriHealth Cancer Institute, Cincinnati
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Prebieha náborObservačná štúdia
- Massive Bio SYNERGY-AI site, Cincinnati
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
Prebieha náborFáza 1
- The Christ Hospital Cancer Center, Cincinnati
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
Prebieha náborObservačná štúdia
- University of Cincinnati Medical Center, Cincinnati
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Prebieha náborObservačná štúdia
- TriHealth Cancer Institute, Cincinnati
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Prebieha nábor
- University of Cincinnati, Cincinnati
- West Chester Hospital (OH394), West Chester · 15 míľ odtiaľ
Štúdie Rakovina (všetky typy) v iných mestách
- Houston, TX121 štúdií
- New York City, NY110 štúdií
- Boston, MA86 štúdií
- Los Angeles, CA73 štúdií
- Nashville, TN65 štúdií
- Philadelphia, PA59 štúdií
- Durham, NC58 štúdií
- Washington, DC58 štúdií
- Chicago, IL51 štúdií
- Seattle, WA49 štúdií
- Atlanta, GA49 štúdií
- Arlington, VA48 štúdií
Iné štúdie v Cincinnati
- Nemalobunkový karcinóm pľúc35 štúdií
- Rakovina prsníka25 štúdií
- Srdcové zlyhanie24 štúdií
- Kolorektálny karcinóm21 štúdií
- Akútna myeloidná leukémia20 štúdií
- Metastatická rakovina20 štúdií
- Rakovina vaječníkov19 štúdií
- Rakovina pľúc19 štúdií
- Obézita19 štúdií
- Rakovina prostaty18 štúdií
- Mnohonásobný myelóm17 štúdií
- Melanóm17 štúdií
Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.